Form 4 for CGEN COMPUGEN LTD
Accepted 2026-04-27 16:03:18 ET · period of report 2026-04-24 · accession 0001178913-26-002245 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DT | 2026-04-27 16:03 | 2026-04-24 | CGEN | Levine Zurit | SVP, Business Development | M - OptEx | $1.15 | +2,000 | 31.4K | +7% | +$2,300 |
| DT | 2026-04-27 16:03 | 2026-04-24 | CGEN | Levine Zurit | SVP, Business Development | S - Sale+OE | $3.20 | -2,000 | 29.4K | -6% | -$6,400 |
| DT | 2026-04-27 16:03 | 2026-04-24 | CGEN | Levine Zurit | SVP, Business Development | M - OptEx | $0.00 | -2,000 | 52.0K | -4% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Ordinary Shares | 2026-04-24 | M | A | 2,000 | $1.15 | 31,375 | D | — | — | (F1) This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 23, 2025. |
| 2 | Common | Ordinary Shares | 2026-04-24 | S | D | 2,000 | $3.20 | 29,375 | D | — | — | (F1) This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 23, 2025. |
| 3 | Derivative | Share Option (right to buy) | 2026-04-24 | M | D | 2,000 | $0.00 | 52,000 | D | $1.15 · — to 2033-08-03 | 2,000 Ordinary Shares | (F1) This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 23, 2025. (F2) This option vested 25% on September 30, 2024 and the remainder vested or vests in 12 equal quarterly installments thereafter, subject to the Reporting Person's continued service to the Issuer. |